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Abstract. We report the case of an adolescentMoroccangirl with abdominal pain andpalpablemass in the upper right
sideof the abdomen. In the emergencydepartment, an abdominal ultrasound showedhepatomegaly andeight active liver
cysts, compatible with cystic echinococcosis. Serology for Echinococcus granulosus confirmed the diagnosis. Other
sites of localization were excluded. Treatment involved albendazole combined with puncture, aspiration, injection, re-
aspiration, performed only for themostmedial cysts. Periodical follow-upwith abdominal ultrasound andwith abdominal
magnetic resonance imaging showed a progressive involution of all cysts. The treatment with albendazole was stopped
after, overall, 6 months, and monthly ultrasound scan were planned as follow-up. In case of hepatic cysts, E. granulosus
should be excluded, especially in children from endemic countries. A multidisciplinary approach with pediatric infectious
disease specialists, radiologists, and surgeons is fundamental for disease management.
CASE REPORT
We report the case of a 13-year-old girl of Moroccan origin
who moved to Italy in June 2017. She was admitted to our
institution in July because of the presence of worsening ab-
dominal pain and palpable abdominal mass in the upper right
sideof the abdomen. Fatigue, loss of appetite, andweight loss
were also reported. Thismasswaspresent since1 year andno
medical investigationswere performed in the country of origin.
No fever, abdominal pain, neurological or respiratory symptoms,
or contact with dogs, sheep, or other animals were reported
in her previous medical history. In the emergency department,
an abdominal ultrasound (US) showed hepatomegaly and eight
liver cysts, compatible with cystic echinococcosis (CE). The
largest cyst measured about 56 mm in diameter with a mass
effect on the right kidney and the pancreatic head (Figure 1A).
All cysts, except one, appeared active (CE1 according to
the World Health Organization classification). The girl was
admitted to the pediatric ward and blood tests were per-
formed, which showed no hypereosinophilia and a mild in-
crease of serum immunoglobulin E (IgE). The other blood tests
performed, including C-reactive protein (CRP), were normal.
Serology for Echinococcus granulosus showed total immu-
noglobulin (Ig) with indirect hemagglutination > 1:8,192, and
total Ig with enzyme immunoassays > 1:400.
To exclude other sites of localization, a chest X-ray, a fun-
dus oculi, and a brain computed tomography (CT) scan were
performed, all of which produced negative results. To better
characterize the hepatic lesions, an abdominal CT scan was
performed. Treatmentwith albendazole (ABZ) at themaximum
dosage of 15 mg/kg/daily was started. The girl was evaluated
after 2 weeks of medical treatment and puncture, aspiration,
injection, re-aspiration (PAIR) of the two most medial cysts
wasperformedusingethanol. About 20ccof alcoholwasused
for eachof the twocysts and theywere puncturedwith aChiba
needle (18G), and about 60 cc of clear liquid was aspirated
fromeach cyst. The liquidwas sent for laboratory tests and the
parassitologic test was positive for protoscolices, confirming
the diagnosis. Blood tests showed mild hypereosinophilia
(1,728 cell/mm3) and amild increase of CRP (8.84mg/dL) after
the procedure. No complications related to PAIR were de-
tected. Thereafter, an abdominal US was performed, which
showed “detained appearance of the two treated cysts, with
detachemnt of the endocyst and formation of septa. There
was no free liquid in the abdomen. The remaining findings
were unchanged compared with the previous examination”
(Figure 1B). After 10 days, the girl was re-evaluated and blood
tests showed the reduction of both hypereosinophilia and
CRP (2.89 mg/dL). One month after the procedure, an ab-
dominal magnetic resonance imaging (MRI) scan with the
study of the biliar tract was performed and showed “a signif-
icant involution of all eight hepatic hydatid cysts with modest
volumetric reduction, with detained profiles and exfoliation of
the internal parietal portion, with an internal signal mainly
hyper-intense in the high-repetition time (TR) sequences and
isolated to the liver in T1. At the completion of echo tomog-
raphy, at least two presented detachment of the endocyst and
formation of septa. There were no images compatible with the
production of daughter cysts, nor of intra-peritoneal dissem-
ination” (Figure 2A). An abdominal US was also performed
(Figure 1C). The girl was periodically followed-up with US
which showed a progressive involution of all eight cysts with
the medical treatment, and no further alcoholization proce-
dures were required. After about 6 months of treatment, an
MRI was repeated, and “of the known eight cysts, only one in
the VIII segment shows amild increase in size of about 2mm.
All cysts appeared inactive with a pseudotumor aspect (CE4
WHO classification)” (Figure 2B). An abdominal US was also
performed (Figure 1D). Blood examinations, full blood cell
count, serum transaminases, creatinin, and CRP were peri-
odically performed showing normal results. The girl’s gen-
eral conditions dramatically improved with a weight gain of
about 9 kg.
Based on MRI scan findings, the treatment with ABZ was
stopped after overall 6 months, and monthly US scans were
plannedas follow-up.No relapseswereobservedafter 3months
of follow-up.
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FIGURE1. Abdominal ultrasoundappearanceof cysts. (A) Appearanceof cystsat thediagnosis; (B) Detainedappearanceof the two treatedcysts.
The remaining findings were unchanged; (C) Involution of all eight hepatic hydatid cyst; (D) All cysts appeared inactive with a pseudotumor aspect.
FIGURE 2. Abdominalmagnetic resonance imaging andultrasoundof cysts. (A) Magnetic resonance imageperformedonemonth after puncture-
aspiration-injection-reaspiration procedure. An involution of all eight hepatic hydatid cysts with modest volumetric reduction was observed. At the
completion of echotomography, two cysts had thick flakingmembranes, giving a thick semisolid aspect. (B) Magnetic resonance image performed
six month after puncture-aspiration-injection-reaspiration procedure. All cysts appeared inactive with a pseudotumor aspect.
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DISCUSSION
The peculiarity of our case is the presence of eight echi-
nococcal hepatic cysts in a 13-year-old girl. In case of hepatic
cysts, the CE etiology should be excluded, especially in chil-
dren from endemic countries.1–3 In case of the presence
of several cysts with daughter cysts and high-risk rupture
localization, some authors suggest a demolitive surgery ap-
proach. However, after accurately considering risks and
benefits, and their localization and size, a combined approach
with pharmacologic and percutaneous treatment was de-
cided. Asmatter of fact, according to the literature, no specific
indications are available regarding the treatment of multiple
active hepatic cysts.4–6 In our patient because of the high risk
of rupture, the medical treatment alone was not considered
safe. In addition, surgery was not indicated because cysts
were localized in different hepatic segments. Therefore, PAIR
was successfully performed on the two most medial cysts at
higher risk of rupture for their superficiality combinedwithABZ
for 6 months, continued also to prevent secondary CE due to
percutaneous treatment. It is pivotal to individualize treat-
ment, especially in complex cases, when a single approach is
insufficient. Moreover, a multidisciplinary approach with pe-
diatric infectious disease specialists, radiologists, and sur-
geons is fundamental for disease management. A regression
of all cysts (from CE1 to CE4) was observed, but based on
literature, there is a very high risk of relapses. Risk of relapses
for cystswith spontaneous involution is about 3%; being 50%
for cysts regressed with ABZ.6–8 It is important to closely
follow-up those patients with monthly abdomen US to detect
relapses early.
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